The availability of targeted therapies has changed the landscape of cancer treatment in the last few years. And two types of cancer particularly affected by these advances are melanoma and non-small cell lung carcinoma or NSCLC. What role does the laboratory play in the diagnosis and treatment of these cancers? How can pathologists and lab professionals work with oncologists to optimize biomarker testing and improve patient outcomes?
On this episode of Inside the Lab, your hosts, Ms. Kelly Swails, MT(ASCP), and Dr. Ali Brown, MD, FASCP, are joined by Dr. Sanjay Mukhopadhyay, MD, Director of the Lung Pathology Service at the Cleveland Clinic, Ms. Lynnette Pineault, MBA, SCT(ASCP), Operations Manager for Laboratory and Genetic Services for Health Partners, and Mr. Jim Ondick, ASCP Patient Champion and IT Associate at The University of Kansas Health System, to discuss advancements in biomarker testing to improve NSCLC and melanoma cancer care.
Listen in for insight on ensuring equitable patient access to biomarker testing and learn how to register for ASCP’s Immuno-Oncology Microlearning Courses for pathologists and laboratory professionals.
Topics Covered
Connect with ASCP
ASCP
ASCP on Facebook
ASCP on Instagram
ASCP on Twitter
Connect with Dr. Mukhopadhyay
Dr. Mukhopadhyay at Cleveland Clinic
Dr. Mukhopadhyay on LinkedIn
Connect with Ms. Pineault
Ms. Pineault on ResearchGate
Ms. Pineault on LinkedIn
Connect with Mr. Ondick
Mr. Ondick on LinkedIn
Mr. Ondick’s Story on ASCP Patient Champions
Connect with Ms. Swails & Dr. Brown
Ms. Swails on Twitter
Dr. Brown on Twitter
Resources
ASCP Patient Champions
ASCP Immuno-Oncology Microlearning Courses
Inside the Lab in the ASCP Store
Sponsor
Bristol Myers Squibb